- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction to: Remdesivir: A Review in COVID-19 ; volume:83 ; number:14 ; day:4 ; month:9 ; year:2023 ; pages:1349 ; date:9.2023
Drugs ; 83, Heft 14 (4.9.2023), 1349, 9.2023
- Classification
-
Recht
- Creator
-
Blair, Hannah A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-023-01937-x
- URN
-
urn:nbn:de:101:1-2023120810084994690070
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blair, Hannah A.
- SpringerLink (Online service)
Other Objects (12)
Remdesivir: A Review in COVID-19
Remdesivir for the Treatment of COVID-19: A Narrative Review
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Remdesivir: A Review in COVID-19
Remdesivir for the Treatment of COVID-19: A Narrative Review
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Remdesivir: A Review in COVID-19
Remdesivir for the Treatment of COVID-19: A Narrative Review
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
The use of remdesivir outside of clinical trials during the COVID-19 pandemic